Breast Neoplasms: all 12,820 studies

Page 13 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection MarginsRecruitingNCT06835426Not applicable
• Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast CancerNot yet recruitingNCT06835400Phase 3
• A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer PatientsRecruitingNCT06833853
• Phase II Study of Systemic Screening in Pathologic Node Positive Breast CancerRecruitingNCT06833502Phase 2
• A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New YorkRecruitingNCT06833255Not applicable
• Familial Breast Cancer in ChinaNot yet recruitingNCT06833216
• Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)RecruitingNCT06832904Phase 2
• A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer PatientsRecruitingNCT06832202Phase 2
• A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer SurvivorsRecruitingNCT06831838Not applicable
• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceRecruitingNCT06830720
• Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani PopulationRecruitingNCT06830590
• HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBCRecruitingNCT06830382
• Hypofractionated Radiation Fractionation in Breast Cancer Patients with Implant-Based ReconstructionRecruitingNCT06830083Not applicable
• Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After ChemotherapyEnrolling by invitationNCT06828614
• Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
• A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerRecruitingNCT06827236Phase 1/2
• Safety and Efficacy of IMPT or IMRT for Breast CancerRecruitingNCT06826885
• A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer PatientsNot yet recruitingNCT06825975Not applicable
• A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer PatientsNot yet recruitingNCT06825949Not applicable
• Prevention of CIPN Using Compressive TherapyRecruitingNCT06823440Not applicable
• Endoscopy/Robotic Assisted Nipple Skin Sparing MastectomyRecruitingNCT06823414
• Validation of TAD in HER-2 with More Than 2 Lymph NodesEnrolling by invitationNCT06821490
• SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast CancerNot yet recruitingNCT06819319Phase 2
• Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid TumorsRecruitingNCT06819215Phase 1/2
• The Effect of Coconut Oil on AlopeciaRecruitingNCT06818370Not applicable
• To Evaluate the Effectiveness and Safety of Mastectomy Combined With Immediate Breast Reconstruction in Breast Cancer (NJMU-Reconstruction Cohort)RecruitingNCT06817954Not applicable
• BREAST Choice Decision Tool R21 - AIM2RecruitingNCT06817226Not applicable
• Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low SubtypeRecruitingNCT06813456
• Strategies to Decentralize Breast Ultrasound in RwandaNot yet recruitingNCT06812208Not applicable
• A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer PatientsRecruitingNCT06811870Phase 1/2
• Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)Not yet recruitingNCT06811454Not applicable
• The Effect of Oral Administration of Hesperidin and Diosmin in Reducing Paclitaxel-induced Peripheral Neuropathy in Breast Cancer PatientsNot yet recruitingNCT06811220Phase 3
• A Phase IIa Study to Evaluate NBQ72SRecruitingNCT06810804Phase 2
• The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant TreatmentNot yet recruitingNCT06810492Not applicable
• Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell DeviceRecruitingNCT06807502Not applicable
• Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)RecruitingNCT06806930Phase 2
• BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPYNot yet recruitingNCT06806072Not applicable
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyRecruitingNCT06805812
• Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast CancerRecruitingNCT06802757Phase 2
• Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical TrialRecruitingNCT06802172Not applicable
• To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast CancerRecruitingNCT06800989Not applicable
• Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast CancersRecruitingNCT06800612
• Localization of Breast Cancer with the Sirius Pintuition Magnetic SeedRecruitingNCT06799858
• Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast CancerNot yet recruitingNCT06798506
• Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)RecruitingNCT06797635Phase 2
• Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast CancerNot yet recruitingNCT06797622Phase 2
• RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi ArabiaRecruitingNCT06797531
• Targeted Palliative Care Intervention for Patients With Metastatic Breast CancerRecruitingNCT06795529Not applicable
• Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer PatientsNot yet recruitingNCT06795503Phase 3
• Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBCRecruitingNCT06793553Phase 2
• BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADCRecruitingNCT06793332Phase 2
• A Study Comparing the Differences Between Young and Non-young Breast CancerEnrolling by invitationNCT06793306
• MEASUREMENT OF CIRCULATING MUTATION BURDENRecruitingNCT06792721
• Diagnostic Performance of Positron Emission Mammography in Breast CancerNot yet recruitingNCT06792591
• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruitingNCT06790693Phase 3
• Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast CancerRecruitingNCT06790264Not applicable
• A Novel Approach Utilizing Organ Specific Age ProteomicsRecruitingNCT06789653
• A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer PatientsNot yet recruitingNCT06788197Phase 1/2
• Proteomic Analysis of Patients Undergoing Bariatric SurgeryNot yet recruitingNCT06787807Not applicable
• Capecitabine in Low Risk Triple Negative Breast CancerRecruitingNCT06787339Phase 2
• Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast CancerNot yet recruitingNCT06787118Phase 3
• Night-shift Work and Breast CancerRecruitingNCT06786949
• MALE Mamm OrganoidsRecruitingNCT06786663
• Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion ProtocolNot yet recruitingNCT06786585
• QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBCRecruitingNCT06786026Phase 2
• To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.RecruitingNCT06784921
• Phase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsRecruitingNCT06784193Phase 1
• Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander PlacementRecruitingNCT06783179
• A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast CancerRecruitingNCT06781996Phase 3
• NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.RecruitingNCT06781281
• Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer PatientsRecruitingNCT06780748Phase 2
• Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative ChemotherapyRecruitingNCT06780735Not applicable
• A Study of Breast Cancer Risk Factors and Outcomes of People in FloridaRecruitingNCT06780176
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationRecruitingNCT06778863Phase 1
• Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast CancerNot yet recruitingNCT06777537Phase 4
• Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant ChemotherapyRecruitingNCT06777420Not applicable
• Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast CancerRecruitingNCT06776458
• Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid TumorsNot yet recruitingNCT06775236Phase 1/2
• A Phase 1 Study of LNCB74 in Advanced Solid TumorsRecruitingNCT06774963Phase 1
• Prospective Registry of ADC as First- and Second-line Treatment for Breast CancerRecruitingNCT06774027
• Rutgers University Study of the Genetics of Breast Cancer.RecruitingNCT06773897
• Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral MetabolismRecruitingNCT06773533
• Effect of Subanesthetic Dose of Esketamine on Sleep QualityRecruitingNCT06773143Not applicable
• Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast CancerRecruitingNCT06772935Not applicable
• The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical StudyRecruitingNCT06770296Phase 1
• A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast CancerNot yet recruitingNCT06769919Phase 2/3
• HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingNCT06769425Phase 1
• Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast CancerRecruitingNCT06768931Phase 2
• A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine GreenEnrolling by invitationNCT06768268Phase 1/2
• Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.RecruitingNCT06766058Not applicable
• Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast CancerRecruitingNCT06765590Not applicable
• A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesRecruitingNCT06764940Phase 2
• A Composite Assay for HER2-positive Early-stage Breast Cancer ManagementRecruitingNCT06762977
• A New Tool to Promote Patient's Engagement in Their Healthcare ProcessRecruitingNCT06762496
• Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,RecruitingNCT06762483
• Quality of Life After Breast Cancer SurgeryRecruitingNCT06761196
• A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
• Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsRecruitingNCT06760507Not applicable
• "Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"RecruitingNCT06759714
• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)RecruitingNCT06757634Phase 3

← Breast Neoplasms overview